The 5th International Conference on Prehypertension, Hypertension & Cardio Metabolic Syndrome (PreHT 2018)
Hilton Molino Stucky Venice GiudeccaVenice, ITALY Visit the Venue to read more
It is our pleasure to invite you to participate in The 5th International Conference on Prehypertension, Hypertension and Cardio Metabolic Syndrome, which will take place in Venice, Italy from 22-25 February, 2018.
Prehypertension is a part of the continuum from normotension to hypertension it is a part of a dynamic process of stiffening and aging of the arteries and of the heart with its consequences. Patients in the prehypertensive range will become finally hypertensive. Diseased arteries will not only participate in propagation of end organ damage but will enhance the progression of additional damage in the arteries and the heart. Understanding the risk of borderline conditions in the metabolic syndrome will enable us to understand the nature of end organ damage and will create a possibility of better prevention of this continuous process.
Prehypertension is usually associated with other components of the metabolic syndrome i.e. obesity, diabetes, glucose intolerance and dyslipidemia. This association is due to common mechanistic pathways and has implications on cardiovascular complications. Diet and exercise with or without drug therapy benefit all components of the metabolic syndrome. Antihypertensive medications may lead to deterioration in glucose tolerance while glucose lowering agents may affect blood pressure. Thus, any discussion about the approach to prehypertension must be done in context to the whole cardio metabolic risk.
The association of multiple CV risk factors enhances rate of progression of end organ damage and affects morbidity and mortality. The presence of multiple risk factors changes the prognosis of the patients and should affect our therapeutic approach- an area with insufficient information and guidelines.
Systolic blood pressure (BP) of less than 140 mm Hg and diastolic BP of less than 90 mm Hg were for years considered as normal. Mounting evidence suggest that BP in the high reference range is associated with an increased risk of cardiovascular disease. The ESH report of 2006 defined it as “high normal” and the seventh report of the Join National Committee on the Prevention, Detection, Evaluation and Treatment of High Blood Pressure defined a new BP category “Prehypertension” for systolic and diastolic BP: 120 to 139 mm Hg and 85 to 89 mm Hg, respectively. This new category is a continuum to hypertension and is a risk factor for cardiovascular disease.
In most developing countries and in the urban areas of many countries, one in five to one in three adults fall in the category of prehypertension. Recommendation and guidelines in the field have substantial public health importance and enormous economic consequences.
The Conference will aim to deal with all aspects related to early diagnosis, including innovative technologies and treatments and will bring together professionals from the fields of Hypertension, Nephrology, Endocrinology, Internal Medicine, Cardiology and more.
We hope that you will join us for what promises to be a stimulating professional and educational event and look forward to welcoming you to Venice.
Stevo Julius Giuseppe Mancia
Enrico Agabiti-Rosei Daniel A Duprez
Hermann Haller Gianfranco Parati
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
Cancellations/changes received up to 60 days prior to arrival – full refund less Euro 50 handling fee.
Cancellations/changes received between 60 to 45 days prior to arrival – 1 night cancellation charge.
Cancellations/changes received Between 45 days to 21 days prior to arrival – 2 nights cancellation charge
Less than 21 days prior to arrival – no refund
Abstract submission deadline 2017-10-30
Participants who would like to present their work must submit an abstract in English for consideration by the International Scientific Abstract Review Committee. A maximum of 3 abstracts, per participant, may be submitted. The committee will be responsible for acceptance as an oral or poster presentation or rejection for each submitted abstract.
Only abstracts of authors who have paid their registration fees will be scheduled and included in the Congress materials.
Rules for Submission:
An author from each abstract is expected to attend the congress and present the poster or oral presentation.
All abstracts must be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication. If you need help, please arrange for the review of your abstract by a colleague who is a native English speaker, by a university scientific publications office (or other similar facility) or by a copy editor, prior to submission.
Only abstracts of authors’ who have paid their registration fees by November 20, 2017 will be scheduled for presentation.
Guidelines for Submission:
Before you begin, please prepare the following information:
Presenting author’s contact details:
Full postal address
Daytime and evening phone number
Presentation type – please choose from one of the following:
Author and co-authors’ details:
Full first and family name(s)
Affiliation details: department, institution / hospital, city, state (if relevant), country
Abstract title– limited to 20 words in UPPER CASE
Abstract text– limited to 250 words (Please Note: Word count is affected when graphs/tables/images are added)
Abstract topic– abstracts must be allocated to a specific topic for the Scientific Program. Please choose from the list of topics.
Tables– A maximum of 3 tables of up to 10 rows x 10 columns can be included per abstract
Graphs and images– It is important to note that each image included in the abstract is worth 30 words. A maximum of 3 images can be included per abstract. The maximum file size of each graph/image is 500 KB. The maximum pixel size of the graph/image is 600(w) x 800(h) pixel. You may upload graphs in JPG, GIF or PNG format.
Draft abstracts– The submission form at the link above allows you to store your abstract as a draft in order to make changes. Please note that abstracts must be SUBMITTED before the deadline in order to be sent to review for inclusion in the Scientific Program.
Take this unique opportunity to join Prehypertension 2018 Conference and to effectively reach hundreds of the world’s leading international medical professionals.
A full range of sponsorship options has been created to allow each company the opportunity to showcase their organisation as it best suits their needs and budget and to have a full access to all networking benefits.
For more information please contact:
Project Manager – Industry Liaison
In compliance with the instructions given by the Legislative Order 219 of the 24th April 2006 – art. 124, to obtain the AIFA application documents, all participants and sponsors from Italy who plans to attend our congress are require to contact Alijet & Fargo International S.r.l:
Alijet & Fargo International Srl
Via P. Maroncelli 44-46-48-50
Tel +39 055/600555
Â email: email@example.com
PreHT 2018, Contact: Liat Halevy
Paragon Group - www.paragong.com
18 Avenue Louis-Casai, 1209 Geneva, Switzerland
Tel: +41 22 5330 948